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Several staphylococcal toxins are among a growing number 
of immunostimulatory molecules called "superantigens" be-
cause of their ability, when presented by appropriate major 
histocompatibility complex class II+ accessory cells, to acti-
vate essentially all T cells bearing particular T-cell receptor 
V jJ gene segments. We have examined the ability of murine 
epidermal Langerhans cells andj or keratinocytes to act as 
accessory cells in the T-cell response to the superantigens 
staphylococcal enterotoxin B and exfoliative toxin, also 
known as epidermolysin. Purified murine splenic T cells 
were stimulated with staphylococcal enterotoxin B or exfo-
liative toxin in the presence of Langerhans cells - enriched 
epidermal cells from normal mice or epidermal cells isolated 
from mice pretreated with recombinant interferon-y, a pro-
cedure that induces the expression of major histocompatibil-
ity complex class II molecules on keratinocytes. The data 
show that both Langerhans cells and class II - bearing kerati-
nocytes can act as accessory cells in the T-cell response to 
staphylococaal enterotoxin B and exfoliative toxin. We also 
observed that both human and murine keratinocytes cultured 
T he family of toxins produced by Staphylococcus aureus includes the staphylococcal enterotoxins (SEs), exfo-liative toxin (ExT), and toxic shock syndrome toxin-1 (TSST-1), the causative agents in food roisoning [1], staphylococcal scalded skin syndrome l2], and toxic 
shock syndrome [3), respectively. Other bacteria have also been 
shown to produce toxins or mitogens, such as pyrogenic exotoxins 
[4] and mycoplasma arthriditis mitogen [5], which resemble the 
staphylococcal toxins. Several of these toxins have been shown to 
bind specifically to human and mouse major histocompatibility 
complex (MHC) class II antigens [6], and all belong to a growing 
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in the presence of staphylococcal enterotoxin B or exfoliative 
toxin produce increased amounts of cytokine(s) capable of 
stimulating thymocytes and 010 cells, and that this toxin 
activity is independent of the level of expression of class II on 
keratinocytes. Studies by enzyme-linked immunosorbent 
assay showed that staphylococcal enterotoxin B stimulates 
keratinocytes to produce tumor necrosis factor-a but not 
interleukin-l, suggesting tumor necrosis factor-a and per-
haps other cytokines are responsible for the T-cell prolifera-
tive activity. These results demonstrate that two distinct epi-
dermal constituents (i.e. Langerhans cells and keratinocytes) 
can serve as accessory cells in the responses of T cells to 
superantigenic bacterial toxins. It is possible that such toxins 
contribute to the pathogenesis of a variety of skin diseases by 
either locally activating T cells bearing particular VjJ genes 
andjor enhancing keratinocyte production of immunomo-
dulatory cytokines. Key words: superantigens/Langerhans cellsj 
class II - bearing keratil1ocytes/cytokines. ] Invest Dermato! 
102:31-38,1994 
group of immunostimulatory molecules called "superantigens" be-
cause of their ability to induce proliferation of essentially all T cells 
bearing particular V{J gene segments [7 -11]. SEs and TSST -1 have 
also been shown to be potent inducers of interleukin-1 (IL-1) and 
. tumor necrosis factor (TNF) in monocytes (12-16]. Recently, the 
ability of these toxins to induce monocyte-derived IL-1 and TNF 
has been shown to result from signal transduction through class II 
following toxin binding [16J. It is likely that many of the pathologic 
effects of these toxins are due to their ability to activate T cells and 
monocytes. 
The term "skin-associated lyrnphoid tissue" (SALT) has been 
used to denote a specific region of immunologic influence equipped 
with essential and unique capabilities for dealing with antigenic 
challenges common to the skin. Principal cellular components of 
SALT include 1) unique antigen-presenting cells, Langerhans cells 
(LC); 2) keratinocytes capable of producing immunomodulating 
cytokines, such as IL-1; 3) Thy-1+ CD3+ T-cell receptor (TCR) 
yJ+ dendritic epidermal T cells (DETC); 4) a subset of recirculating 
T cells that share a skin-specific homing receptor, and 5) specialized 
post-capillary endothelial venules capable of expressing a skin-spe-
cific address in [17,18]. Because of its location at the interface of the 
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host with the external environment, the skin is constantly exposed 
to a wide variety of potentially harmful environmental agents, in-
cluding bacteria. As noted above, several bacteria, in particular 
Staphylococcus aureus, produce superantigenic toxins that are asso-
ciated with several skin disorders. These include staphylococcal 
scalded ski.n syndrome in which exfoliation of the skin occurs [2], 
toxic shock syndrome in which rash and skin desquamation occur 
[3], and group A streptococcal infections that show cutaneous 
swelling, erythema, and desquamation [4]. Such associations of skin 
disorders and superantigen presence led us to examine the immuno-
modu latory consequences of bacterial toxins in skin. In this paper 
we report that not only LC but also class II - bearing keratinocytes 
can function as accessory cells in the T-cell response to the superan-
tigens SEB and ExT. We have also observed that keratinocytes 
cultured in the presence of SEB and ExT exhibit augmented pro-
duction of cytokine(s) with T-cell - proliferative activity. 
MATERIALS AND METHODS 
Animals Female BALB/c and CBA/J mice were purchased from the 
Jackso n Laboratory (Bar Harbor, ME) and used at 7 - 12 weeks of age. 
Toxins, Mitogens, and Other Chemicals SEB was purchased from 
Sigma C hemical Co. (St. Louis, MO), ExT from Toxin Technology (Madi-
son, WI), and phytohemagglutinin (PHA) from Gibco Laboratory (Grand 
Island, NY). In both 100 and 1000 ng/ml SEB, no endotoxin activity was 
detected by limulus test. Pertussis toxin and diphtheria toxin were purchased 
from Gibco BRL (Gaithersburg, MD). 
Working solutions of all-trans retinoic acid and phorbol-12-myristate-13 
acetate (PMA) (Sigma) were prepared from stock solutions in dimethylsul-
phoxide in the appropriate culture medium at the time of use. The greatest 
fina l concentration of dimethylsu lphoxide in the cultu re was less than 
0.025%. 
Monoclonal Antibodies (MoAb) The following MoAb were used for 
antibody + complement (C') de~letion at the indicated concentrations: 
212A1 (anti - I_Ad; 50 mg/ml) [19] and 30H12 (anti - Thy-1.2; 1:400 dilu-
tion; Cedarlane, Ontario, Canada). A cocktail of the fo llowing MoAbs was 
used for Ab + C' depletion of LC and DETC: Mac- l (anti-CR3; found on 
human and murine monocytes and macrophages; 3 ttg/ml) [20], 2.4G2 
(anti-FeR; found on murine macrophages and LC; lOttg/ml) [21], and CLA 
(anti-murine C D45; found on all bone marrow - derived cells; 1:5 dilution 
of hybrid om a cultu re supernatant; American Type Culture Collection) [22]. 
Mar18.5 (mouse an ti-rat kappa; 20 ttg/ml) [23] was used to crosslink the 
three preceding MoAb to enhance C' mediated cytolysis as previously de-
scribed [24J. 
Preparation of Epidermal Cell (EC) Suspensions Murine EC suspen-
sions were obtained from ear skin . Ears were excised at the base and split 
along the plane of the cartilage, which was then removed together with the 
subcutaneous tissue. The specimens were incubated for 1 h at 37 'C in a 
0.25% trypsin solution (Gibco). Epidermal cells dispersed in phosphate-buf-
fered saline (PBS) supplemented with 10% feta l bovine serum (FBS) were 
then fi ltered through a cotton column and washed twice in PBS. Viability at 
this point was typically greater than 90% as assessed by trypan blue dye 
excl usion, and more than 80% of viable cells had a small spherical configura-
tion (9 - 15 ttm in diameter) , characteristic of basal keratinocytes. 
Human EC suspensions were isolated from newborn foreskins following 
overnight incubation (4 ' C) in 0.25% trypsin. A single cell suspension was 
prepared as above and cultured in se rum-free keratinocyte growth medium 
(KGM; C lonetics Corp., San Diego, CAl on collagen-coated microtiter 
plates. To prepare the collagen-coated plates, 15 ml ofVitrogen 100 (puri-
fied collagen in 0.012 N HC1; Collagen Corp., Palo Alto, CAl diluted 1 :14 
with sterile distilled water was added to each well of 96-well fl at-bottom 
micro titer plates (Corning Glass Works, Corning, NY) . Collagen was po-
lymerized by a 30-min exposure in an atmosphere of ammonia, and the wells 
were dried overnight and rinsed twice with sterile distilled water. Semicon-
fluene cultures of human keratinocytes were obtained by cultivating freshly 
isolated foresk in EC in KGM on the collagen-coated plates for approxi-
mately 1 week. 
For preparation of LC-enriched EC (LC-EC), freshly isolated single cell 
suspensions of murine EC (2 X 106 cells/ml) were cultured in plastic dishes 
(10 em in diameter; Corning) for 24 h in RPMI-1 640 containing 10% FBS, 
2.5 X 10- 5 mol/ l 2-mercaptoethanol , 100 units/ml penicillin, and 100 ttg/ 
ml streptomycin. Nonadherent cells were then centrifuged over a Ficoll -
Hypaque gradient (specific gravity 1.083; Sigma) and interface cells were 
collccted and washed in RPMI-1640. LC-EC typica lly contained 10-30% 
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I-A+ cells and 5-20% Thy-l+ cel ls as assessed by immunoHuorcscel1ce 
microscopy. 
Treatment with MoAb Plus C' EC or LC-EC (5 X 106/ml) were incu-
bated with the appropriate MoAb in RPMI-1640 for 45 min at room tem-
perature. The cells were then washed three times and resuspended in a 1:10 
dilution of Low-Tox-M rabbit C' (Cedarlane) in RPMI-1640 for 45 min at 
37 'C. Cells were then washed twice and resuspended in culture medium. 
Preparation of Class II-Bearing Keratinocytes Murine class IJ+ ker-
atinocytes were prepared by in vivo administration ofinterferon-y (IFN-y) , as 
previously described [24]. Briefly, 50,000 units of murine rlFN-y (Genzyme 
Corp., Boston, MA) was adminjstered intraperitoneally for six consecutive 
days. The day following the final injection, EC suspensions (IFN-y-EC) 
were prepared as described above. The expression of class II molecules on 
keratinocytes from IFN-y- treated mjce was confirmed by flow-cytometric 
ana lysis using anti-I-Ad MoAb. Compared with keratinocytes from un-
treated mice, all spectra of the fluorescence intensity of keratinocytes from 
IFN-y- treated mice were shifted to higher intensity. 
Proliferation Assay for T-Cell Response to SEB and ExT Splccn cell 
suspensions were prepared and erythrocytes were lysed in 0.83% ammonium 
chloride. Then , the cells were suspended in RPMI-1640 (Gibco) containing 
10% heat-inactivated FBS and passed through a prewarmed nylon wool 
column as described [25J. In some experiments, to obtain high ly purified T 
cells, spleen ct;lls were incubated in a rabbit anti-mouse immunoglobulin 
(DAKO Co., Carpinteria, CAl - coated plate for 2 h at 37'C. Nonadherent 
cells were then passed through a nylon wool column. 
Splenocytes, thymocytes, and nylon wool - purified or highly purified 
splenic T cells were suspended in RPMI-1640 supplemented with 10% 
heat-inactivated FBS, 2 mmol/l L-glutamine, 2.5 X 10-5 M 2-mercap-
toethanol, 100 units/ml penicillin, and 100 ttg/ml streptomycin. Cells 
(3 X lOs cells/well) were then cultured with SEB or ExT in the presence or 
absence of EC, LC-EC, or IFN-y-EC. In some experiments, 3000 rad-
irradiated LC-EC were used as accessory cells. When EC were employed as 
accessory cel ls, indomethacin (Sigma) was added to the cultures at a final 
concentration ofl ).lg/mJ. Cultures were maintained in 96-well flat-bottom 
microtiter plates (Corning) at 37'C, 5% CO2 for 66-70 h. One ).lCi/well 
methyl tritiated thymidine ('H-TdR; Amersham International, Arlington, 
IL) was added 14 - 16 h before harvest. Cells were harvested on glass fiber 
filters using an automated cell harvester (Cambridge Technologies, Water-
town, MA) and JH-TdR uptake w as measured using a scintillation counter. 
Preparation of Culture Supernatants and Extracts from Murine 
Keratinocytes Freshly isolated BALB/c BC were suspended in Dul-
becco's modified Eagle's Medium (DMEM; Gibco) containing 10% FBS, 
2.5 X lO- s mol/l 2-mercaptoethanol , 100 units/ml penicillin, and 100 
).lg/ml streptomycin. Cells (7 X 106 cells/well) were then cultured (1.2 
ml/well) in the presence or absence of SEB or ExT ill 24-wcll plates (Corn-
ing) at 37'C, 5% CO2 , After 2 d supernatants were harvested, dialysed 
against RPMI-1640, and stored at -20' C. In addition, the cultured cells 
were washed with RPMI-1 640, resuspended in 1.2 ml of RPM I-1640, and 
subjected to three cycles of freezing (-70 'C) and thawing (37 ' C) . Result-
ing lysates were centrifuged at 10,000 X g at 4 ' C for 30 min and the super-
natant collected. After dialysis against RPMI-1640, tbe extracts were stored 
at -20 ' C. 
Preparation of Supernatants from and Analysis ofHLA-DR Expres-
sion on Human Keratinocytes Semiconfluent cultures of human kerati-
nocytes in 96-well plates were incubated for 24 h in the presence or absence 
of 500 units/ml human rlFN-y (Genzymc), and then were analysed for 
HLA-DR expression by enzyme-linked immunosorbent assay (ELISA), or 
were used for examining the effect of SEE on cytokille production. 
For live-cell ELISA, keratinocytes were incubated with 2% bovine serum 
albumin for 1 h at 4'C and washed twice. Allti - HLA-DR (IVA12, Ameri-
can Type Culture Collection; 100/11 hybridoma culture supernatant) was 
then added to each well and incubated for 1 h at 37'C. Wells were then 
washed three times with Tris-buffered saline (TBS; pH 7.5). Then, 100)11 of 
alka line phosphatase-labeled goat anti-mollse IgG (Pierce Co., Rockland, 
IL) was added at a final dilution of 1:2500. Wells were incubated 1 h at 
37 'C, washed three times with TBS, and the alkaline phosphatase activ ity 
detected by incubation with nitro-phenyl phosphate in 10 mmol/l diethan-
olamine for 20 min at room temperature. The substrate reactivity was moni-
tored by absorption at 405 nm. Preliminary studies showed that expression 
of HLA-DR was maximum 24 - 48 h after the addition of IFN-y. Results 
obtained using this methodology arc similar to those previously reported 
using flow-cytometric analysis (26J. 
To examine the effect of SEB on epidermal cell - derived thymocyte-acti-
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Figure 1. Proliferative responses to SEB or ExT of splenocytes, thymo-
cytes, and splenic T cells from BALB/c mice. A,C: Responses to SEB (A) or 
ExT (C) of splenocytes (3 X lOs/well) and thymocytes (5 X lOs/well). 
B,D: Responses to SEB (B) or ExT (D) of crude splenocytes (3 X lOs/well) 
and nylon wool column-purified splenic T cells (3 X lOs/well) . Oata 
points represent the mean ± so of triplicate cultures. 
vating factor (ETAF) production, semiconfluent keratinocytes that had been 
cultured with or without IFN-y were washed with KGM and further incu-
bated for 24 h with 200 ng/ml SEB in OMEM containing 10% FBS. Super-
natants were then collected and assayed for the presence of ET AF activity as 
described below. 
Bioassays for T-Cell-Activating Cytokines 010.G4.1 (010) cells 
[27] were used 3 weeks after their last stimulation with antigen, fceder cells, 
and T-cell growth factor. 303 [27], an anti-OlO TCR clonotypic MoAb, 
was used at a final concentration of 10 ng/lIl!' CBA/J thymocyte suspen-
sions were prepared and used for ETAF assay, i.e., augmentation of lectin-
induced thymocyte proliferation as described previously [28]. Triplicate 
cultures of 010 cells (2 X 104/well) plus 303, or of thymocytes (106/well) 
plus PHA (0.8%) were incubated in supplemented RPMI in 96-well plates in 
the presence of serial fourfold di lutions of culture supernatants or cell ex-
tracts from murine or human keratinocytes. Cultures were incubated for 
60-65 h at 37"C in 5% CO2 , Wells were pulsed with 3H-TdR (1 /lCi/well) 
10- 14 h before harvest. 
For examining the synergistic effect berween IL-la and TN Fa, 010 cells 
(2 X 104/well) plus 303, or thymocytes (106/well) plus PHA were cultured 
for 3 d in 96-well plates with varying doses of murine rIL-la and/or murine 
rTNFa (Genzyme). 3H_ TdR incorporation was assessed as described above. 
ELISA for IL-la and TNFa in Culture Supernatants from Human 
Keratinocyte Semiconfluent human keratinocytes were incubated in 24-
well plates (2 ml culture medium/well) for 48 h with SEB, pertussis toxin, 
diphtheria toxin, all-trat/s retinoic acid, or PMA in OMEM containing 10% 
FBS and antibiotics. Commercially available ELISA kits (Otsuka Pharma-
ceutical Co., Tokushima, Japan) were used for measuring human IL-la and 
TNFa in the supernatants. The data were expressed as mean of triplicates. 
Statistical Analyses The Student t test was used to determine the statisti-
cal difference berween mean values. 
RESULTS 
Proliferative Responses of Splenocytes, Thymocytes, and 
Purified T cells to SEB or ExT Varying doses of SEB were 
added to crude (un purified) splenocytes, thymocytes, and nylon 
wool-purified splenic T cells from naive BALB/c mice, and the 
proliferative responses measured (Fig 1). T cells capable of respond-
ing to SEB have been reported to express TCRs containing V/3 7, 
8.1,8.2,8.3, and 17 [7 - 11]. However, in BALB/c mice (I-E+, Mis 
I b2') this response is mediated by V/38+ (and possibly V/37+) cells 
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only, because virtully all V/317-bearing T cells are deleted during 
fetal/neonatal thymic ontogeny [29]. Compared with the spleno-
cyte response, the response of thymocytes to SEB was minimal (Fig 
lA), a result expected given the relatively low proportions in thy-
mocyte suspensions of both mature, functional T cells, and MHC 
class II+ cells (see also below). 
The proliferative response ofT cells to staphylococcal superanti-
gens is dependent upon the presence of MHC class II+ accessory 
cells [7 - 11 J. Consistent with this observation, splenic T cells puri-
fied by passage over nylon wool gave greatly reduced responses to 
concentrations of SEB ranging from 1 to 100 ng/ml (Fig IB) . At 
high SEB concentrations (1000 ng/ml) significant proliferative re-
sponses were observed, most likely because a single passage over 
nylon wool did not remove all accessory cells from the spleen cell 
suspension. A similar pattern of proliferation was seen in the re-
sponse of BALB/c cells to a second superantigen, ExT (Fig 1 C,D), 
previously shown to stimulate T cells bearing V/33, 10, 11, 15, and 
17 [10,11]. Therefore, unless otherwise indicated, standard concen-
trations of 100 ng/ml of toxins were employed in subsequent ex-
periments. 
Lack of Responsiveness ofEC to SEB or ExT EC suspensions 
primarily contain keratinocytes, LC, and DETC. Prior to examin-
ing the ability ofLC and/or keratinocytes to act as accessory cells for 
the response of purified splenic T cells to superantigens, it was 
neccessary to determine whether the superantigens could directly 
induce EC proliferation. The results of several experiments are 
summarized in Table I. Neither crude EC, LC-EC, nor EC from 
IFN-y-treated mice (IFN-y-EC) proliferated significantly in re-
sponse to SEB or ExT. The high baseline LC-EC proliferation (in 
the absence of SEB/ExT) appears to be due to DETC, as treatment 
of LC-EC with anti - Thy-l + C' abrogates this response. Because 
Thy-l is also known to be expressed on some keratinocytes, alterna-
tive exlanation for the sensitivity of the baseline proliferation of 
LC-EC to anti-Thy-l + C' is the preferential expression of the 
Thy-1 antigen on a subset of more rapidly cycling keratinocytes. 
These data indicate that EC, including its resident population of 
CD3+ TCR yl5+ DETC, are not activated to proliferate in response 
to the superantigens SEB or ExT. 
Both LC-EC and IFN -y-EC Can Serve as Accessory Cells for 
Superantigen Responses To examine the abilities of various 
populations of EC to serve as accessory cells for superantigen re-
sponses, purified splenic T cells were cultured with SEB or ExT in 
the presence of syngeneic crude EC, LC-EC, or IFN-y- EC (Fig 2). 
LC are the only epidemal cells to constitutively express class II 
antigens in normal mice [30]. Crude EC suspensions typicaJly con-
tain 90 - 95% keratinocytes, and only very low numbers of LC 
(0.5 - 3%) [31]; such crude suspensions, at least at the cell concentra-
tions employed, were only able to provide minimal accessory cell 
activity for the responses of purified splenic T cells to either SEB or 
ExT. In contrast, when crude EC suspensions are first cultured for 
24 h, the nonadherent cells collected and centrifuged over Ficoll-
Hypaque, and then the cells at the interface collected, the resulting 
suspension is markedly enriched for class 11+ LC (10-30%). The 
accessory cell activity of such LC-EC for purified T-cell responses 
to SEB and ExT is also markedly enriched. Pretreatment of mice for 
several days with daily intraperitoneal injections of IFN-jl has pre-
viously been shown to induce the expression of class II MHC on the 
majority of keratinocytes [24]. Crude EC suspensions freshly iso-
lated from such pretreated mice (IFN-y-EC) , without additional 
24-11 culture or centrifugation over Ficoll-Hypaque, were able to 
provide accessory cell activity for purified T cells to SEB and ExT 
that was quantitatively comparable to that seen using LC-EC. To 
confirm the accessory cell ability ofEC components, T cells highly 
purified by adherence to an anti-immunoglobulin antibody-coated 
plate and nylon wool column passage were used for testing the 
ability of LC-EC to induce T-cell proliferation to SEB. As shown in 
Table II, no response of highly purified T cells was observed with 
100 or 1000 ng/ml SEB. On the other hand, Tcells were stimulated 
with SEB at these doses in the presence of irradiated LC-EC. Thus, 
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Table I. Responses of EC to SEB and ExT 
Toxin 
SEB 
ExT 
Cell Type 
CrudeEC 
LC-EC 
LC-EC (aThy-1 + C') 
IFN-y-EC 
LC-EC 
0 
540 570 
8670 9140 
940 910 
780 990 
7330 6920 
3H-TdR Incorporation (cpm)' 
Dose of Toxin (ng/rnl) 
10 102 
750 760 
9190 7870 
910 780 
830 790 
6980 6320 
103 10' 
840 680 
9880 12100 
930 990 
850 950 
8010 7900 
"I X 10' crude EC, LC·EC, LC-EC treated with anti- Th)'-I plus C, or IFN-y-EC were cultured for 3 d in the presence of the indicated dose ofSEB or ExT. Wells were pulsed 
with 3H-TdR for the last 16 h prior to harvest. Values represent rneans of triplicate cultures. 
LC-EC were capable of inducing the T-cell response to SEB in the 
condition that splenic antigen-presenting cells were completely de-
pleted. 
Both LC and Class 11+ Keratinocytes Can Serve as Epidermal 
Accessory Cells for the SEB Response of Purified Tcells To 
determine which cells in the EC suspensions were functioning as 
accessory cells in the response of purified T cells to SEB, studies 
utilizing antibody + C' depletion were performed (Table III) . Puri-
fication ofT cells with nylon wool column was varied in its efficacy 
and very small numbers of contaminated splenic accessory cells 
could induce T-cell responses to SEB. In each experiment, the data 
of no-accessory cell-addition groups (purified T cells plus SEB) 
represent the T-cel! responses to SEB induced by residual splenic 
accessory cells not completely depleted. The enhanced responses by 
the addition of epidermal accessory cells treated with C' alone re-
flect the accessory celJ ability of Ee. Experiment 1 shows that pre-
treatment ofLC-EC with anti- class II (anti -I_Ad) + C' completely 
abrogated their ability to function as accessory cells . Because LC are 
the only MHC class 11+ cells in normal epidermis, this data indi-
cates that LC can function as accessory cells for superantigen re-
sponses. However, IFN-y-EC suspensions contain both class II+ 
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Figure 2. Responses of purified T cells to SEll and ExT in the presence of 
epidertna l ce ll s. Purified T cel ls were cultured with 100 ng/ ml SEB (A) or 
ExT (B) in the presence of the indicated number of crude EC, LC-EC, or 
IFN-y-EC per well. In both experiments, indomethacin (1 Jig/ml) was 
added to the cultures. Data points represent the mean ± SD of triplicate 
cultures. 
LC as well as class II+ keratinocytes, and to assess the potential 
contribution of such keratinocytes in superantigen responses, it was 
necessary to utilize an alternate method to deplete the LC from 
IFN-y-EC suspensions that did not depend on their constitutive 
expression of class II. A panel of MoAbs directed against other 
antigens expressed on bone marrow - derived cells such as LC, but 
not on epidermal keratinocytes, has previously been used to exam-
ine the antigen-presenting properties of class U+ keratinocytes in 
IFN-y-EC [24]. Thus, a similar panel of MoAbs (directed against 
Mac-i, 2.4G2, and CLA, follow ed by MARlS.S to crosslink and 
enhance subsequent CO-mediated cytolysis) was employed to de-
plete LC from EC suspensions. This treatment was as effective as 
anti - class II in abrogating the accessory cell function of LC-EC 
when tested at 100 ng/ml SEB (experiment 2) and resu lted in ap-
proximately an 80% reduction of the T-cell response at 200 ng/ml 
SEB (experiment 3). In contrast, similar pretreatment ofIFN-y-EC 
had no effect on the ability of th e remaining cells to serve as acces-
sory cells forT cells responding to 200 ng/ml SEB (experiment 4) . 
These results strongly suggest that class 1I+ keratinocytes are also 
capable of acting as accessory cells for superantigen responses. 
SEB and ExT Augment Production of T-Cell-Activating 
Cytokine(s) by Murine and Human Keratinocytes In addi-
tion to their superantigenic properties, SEs and TSST-1 have been 
shown to be potent inducers of IL-l and TNF in monocytes [12-
16J. To determine whether superantigens might affect cytokine 
production by keratinocytes , murine EC were cultured for 2 d in the 
presence or absence of SEB or ExT. The T -cell- proliferative activ-
ity was then measured by analyzing the abi lity of culture superna-
tants and cell extracts to support the proliferation of PHA-stimu-
lated CBA/J thymocytes or the 010 Tcelliine. CBA/J thymocytes, 
which in preliminary experiments (done in parallel with those 
shown in Fig 1) were found to be unresponsive to SEB, were used to 
assay ETAF activity in SEB-containing samples. The TCR ex-
pressed by Di 0 contains the SEB-responsive variable region VpS.2, 
and 010 has been shown to proliferate in response to SEB even in 
the absence of accessory cells 19]. However, Vp8 .2-bearing cells do 
Table II. Responses of Highly Purified T Cells to SEB in the 
Presence of Irradiated LC-EC 
SEB 3H_ TdR Incorporation' 
T Cells LC-EC (ng/ml) (cpm ± SD) 
+ 940 ± 140 
+ + 450 ± 70 
+ 100 780 ± 310 
+ + 100 14640 ± 440 
+ 1000 880 ± 350 
+ + 1000 15810 ± 2420 
'T cells (3 X lOS/well) purified with an anti-mouse immunoglobulin-coated plate 
and nylon-wool column were cultured with the indicated concentration ofSEB in the 
presence of irradiated LC-EC (1 X lO'/well). Indomethacin (lpg/ml) Was added to 
the culture. 
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Table III. Effects of MoAb + C' Pretreatment on the Accessory Cell Functions of LC-EC and IFN-y - EC in the 
T-Cell Response to SEB 
JH-TdR Incorporation (cpm)' ± SD 
Source of 
Number of Accessory Cells 
Experiment Accessory Cells Treatment 0 2 X 105 105 5 X 10' 
LC-EC 15,280 ± 480 
C' alone NT 68,670 ± 3,400 84,310 ± 8,840 
aI-Ad + C' NT 14,690 ± 1,190 14,230 ± 550 
2 LC-EC 9,040 ± 1,020 
C' alone 20,230 ± 420 NT 14,860 ± 1,330 
MoAbb + C' 6,200 ± 680 NT 7,190±500 
3 LC-EC 21,720 ± 4,400 
C' alone 46,760 ± 3,730 84,710 ± 1,980 NT 
MoAbb + C' 28,790 ± 7,450' 30,470 ± 1,980' NT 
4 IFN-y-EC 12,270 ± 1,540 
C' alone 36,340 ± 4,390 46,170 ± 2,830 NT 
MoAbb+C 36,820 ± 1,530 47,680 ± 80 NT 
'Nylon wool -passed Tcells from BALB/c mice were cultured with SEB (100 ng/ml in experiments 1 and 2, and 200 ng/ml in experiments 3 and 4). 
bThe following cocktail of MoAbs was used in experiments 2 - 4: Mac-l + 2.4G2 + CLA followed by Marl8.S to crosslink. 
'p < 0.001, versus response seen with accessory cells pretreated with C' alone. 
Ip < 0.01, versUS response seen with accessory cells pretreated with C' alolle. 
not proliferate in response to ExT [8]' and therefore 010 cells could 
be used to assay T-cell-proliferative activity in ExT-containing 
samples. As shown in Table IV, EC cultured in the presence ofSEB 
or ExT show a dose-dependent increase in T -cell-proliferative ac-
tivity, both in supernatants and cell extracts. 
We were also interested in investigating the relationship between 
the intensity of class II expression by keratinocytes and their ability 
to produce T -cell- activating cytokine(s) in response to superanti-
gens. We chose to use human primary keratinocyte cultures to 
examine this issue, as ill lIitro IFN-y treatment has been shown to 
induce class II expression by human, but not murine, keratinocytes 
[24,32]. Human keratinocytes cultured in the presence of SEB 
showed increased ETAF activity (Table V). Addition ofIFN-y had 
no effect on the level of ETAF activity detected, but did result in 
increased class II expression as measured by ELISA. We conclude 
that the capacity of SEB to induce increased ET AF activity does not 
correlate with the level of expression of class II on such cells. 
ELISA Analysis of IL-la and TNFa in Supernatants from 
Human Keratinocytes Cultured with SEB IL-la is known to 
be a major keratinocyte-derived cytokine responsible for activation 
of thymocytes and 010 cells [27,33] . However, TNFa, which is 
released by keratinocytes upon stimulation [34) , also is a growth 
factor for thymocytes [35]. As shown in Fig 3, it was confirmed that 
there was a synergistic effect between IL-la and TNFa in the 
stimulation of thymocytes. Furthermore, these two cytokines also 
showed synergism in the prol iferative response of 010 cells. We 
thus performed ELISA for IL-la and TN Fa in the supernatants 
from human keratinocytes cultured with SEB. To compare with 
non-superantigenic bacterial toxins and known stimulators for the 
production of keratinocyte cytokines, pertussis toxin, diphtheria 
toxin, all-trailS retinoic acid [36], and PMA (37) were also tested 
along with SEB. As shown in Table VI, SEB did not augment IL-la 
production by keratinocytes as compared with no addition group, 
whereas the same dose of diphtheria toxin and 20 mM PMA en-
hanced the production of IL-la. Diphtheria toxin and pertussis 
toxin is one of a group of bacterial toxins whose physiologic effects 
are caused by ADP-ribosylation of various target proteins [38]. The 
data suggest that such toxins at appropriate doses induce keratino-
cyte to produce IL-la depending 011 toxins, or that IL-l a might be 
released from keratinocytes because of the cytotoxicity of diphthe-
ria toxin. On the other hand, significant amounts of TNFa were 
produced by the addition of SEB, all-trailS retinoic acid, and PMA, 
but not pertussis toxin or diphtheria toxin. These data suggest that 
although less stimulative than PMA, SEE induces keratinocytes to 
produce TNFa but not IL-la. It is assumed that the SEB-enhanced 
T-cell-proliferating activity in the supernatant stems at least partly 
from the augmentation of TN Fa production by keratinocytes. The 
pattern of cytokine production induced by SEB was comparable to 
that by all-trailS retinoic acid, which has a great ability to induce 
keratinocyte cytokines with IL-l - like bioactivity (36). These re-
sults suggest that TN Fa contributes to the T -cell-activating ca-
pacity of the supernatant in consideration of the synergism of IL-
la/TNFa, but other cytokines are possibly involved in the activ ity. 
Table IV. Effects ofSEB and ExT on T-Cell-Activating Cytokine Production by Murine Keratinocytes 
Toxin 
SED 
ExT 
Cells Used for Assay 
CDAj) thymocytes 
DI0 
Toxin Dose 
(ngjml) 
o 
1 
10 
100 
1000 
o 
1 
10 
100 
1000 
3H-TdR Incorporation ± SD (cpm)' 
Supernatant 
6,550 ± 370 
6,370 ± 920 
10,240 ± 970 
34,080 ± 4,290 
54,940± 11 ,110 
11,000 ± 1,160 
21,550 ± 3,430 
37,620 ± 12,160 
33,010 ± 3,290 
50,220 ± 4,610 
Cell Extract 
1,860 ± 190 
1,520 ± 170 
2,060 ± 340 
2,940 ± 410 
3,940 ± 630 
6,420 ± 850 
7,240 ± 870 
7,560 ± 140 
8,710 ± 110 
10,120 ± 850 
'Freshly isolated Illurine keratinocytes were cultured with the indicated doses of SEB or ExT. After culture for 48 h, T-ccll-prolifcrative activity of the supernatants and cell 
extracts were quantitated by their capacities to augment the proliferation of PH A-stimulated CBAII thymocytes (6n.1 dilution of samples, 1 : t 6) or 303-stimul.ted OlD cells (final 
dilution of samples, 1: 256). The responses of CBA/] thymocytes and 010 cells to 5 units/Ill l o( r1L-la were 9,710 ± 110 and S2.470 ± 2300 cpm, respectively. 
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Table V. Effect of the Intensity of HLA-DR Expression on SEB-Induced ETAF Production in Human Keratinocytes 
Human Keratinocytes 
Incubation' HLA-DR Expressionb ETAF Activity in Supernatant ' 
(cpm ± SO), Final Dilution 
IFN-y SEB 
(00405 ± SO) 
Group (0-24 h) (25-4811) 
A 
B + 
C + 
D + + 
24 h 48 h 
0.17 ± 0.02 0.12 ± 0.D1 
O.4Y± 0.04 0.33' ± 0.01 
1: 4 
7,490 ± 1,940 
(n = 13) 
9,580 ± 2,790 
(n = 11) 
40,600 ± 4,920 
(n = 9) 
39,140 ± 5,360 
(n=9) 
1 : 16 
5,570 ± 1,390 
(n = 12) 
6,230 ± 990 
(n = 11) 
29,230 ± 4,920 
(n=9) 
27,940 ± 4,070 
(n = 9) 
'Multiple semiconlluerlt cultures of human keratinocytes in 96-wel1 microtiter plates were incubated with or without 500 unitS/JIll human rJFN-~ for 24 h. After washing, the 
keratinocytes were cultured in the presence or absence of SEB (200 ng/ml) for additional 24 h. Culture supernatants were harvested at 48 h and tested for IL- l activity. 
bHLA-DR expression on keratinocytes was monitored by ELISA at 24 and 48 h. The value of 00.05 ofketatinocytes in groups C and D stained with an irrelevant control primary 
MoAb, anti -LFA- I, was 0.12 ± 0.01. 
'ETAF activity was quantitated by the capacities of supernatants to enhance 'H-TdR uptake of FHA-stimulated CBA/J thymocytes. The mean cpms of FHA-stimulated CBA/] 
thymocytes cultured with 100 and 25 units/ml of standard rIL- l were 38,210 and 25,380, respectively, whereas thatofPHA-stimulated thymocytes in the presence of 50 ng/ ml SEB 
(the theorctical1y maximum amount of SEB that could be present in 1 : 4 dilutions of 200 ng/ ml SEB-stimulated keratinocyte supernatants) Was 14,230. 
Jp < 0.01, compared with corresponding group C. 
DISCUSSION 
The present series of experiments demonstrate that both LC and 
class 11 - bearing keratinocytes can function as accessory cells for 
T-cell responses to the superantigens SEB and ExT. That LC have 
this capacity is perhaps not particularly surprising, as it has been 
known for many years that LCs function as accessory cells/antigen 
presenting cells in T-cell response to conventional antigens [30] and 
their accessory cell ability for SEB has been recently reported [39]. 
However, it is of particular interest that class II+ keratinocytes can 
function as accessory cells for the response of purified T cells to SEB 
or ExT. A similar firiding has been recently reported by Nickoloff 
et al in human keratinocytes (40) . Keratinocytes are induced to syn-
thesize and express class II at a variety of inflammatory sites [41,42] 
as well as following the chronic administration of exogenous IFN-y 
120 r-------------..., 
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Figure 3. Synergism between IL-la and TNFa in the proliferation of 
thymocytes and 010 ceIls. Thymocytes plus PHA (top) or 010 cells plus 
303 (holtom) were cultured with 0.025 to 6.4 units/ml rIL-la in the further 
addition of the indicated varying doses of rTNFa. The data represent 
mean ± SO of triplicate cultures. 
[24,43] . Previous studies have shown that class II+ keratinocytes are 
unable to stimulate allogeneic T cells in a primary EC-lymphocyte 
reaction, or to present soluble protein antigens to primed antigen-
specific T cells [24,42], and rather induce antigen-specific unre-
sponsiveness in a hapten-specific T -cell clone [43]. In light of these 
previous observations, the present results indicate that significant 
differences exist in the requirements for presentation to T cells of 
conventional antigens versus superantigens by subpopulations of 
intraepidermal class U+ cells. Whereas LC are efficient accessory 
cells in both types of responses, class U+ keratinocytes appear to 
function in a positive manner only in responses to superantigens. 
These findings reinforce previous studies demonstrating that non-
conventional accessory cells, such as class II trallSfected fibroblasts , 
can serve as accessory cells for superantigen responses of normal 
T cells [44] . 
The present studies also demonstrated that murine and human 
keratinocytes release cytokines with thymocyte- and Di0-prolifer-
ative activity following their exposure to staphylococcal toxins. 
Because the toxins produced increased T -cell- activating activity 
not only in culture supernatants but also in cell extracts, the aug-
mented activity represents a total net increase in bioactive cytokine 
production by keratinocytes rather than a simple shift in cytokines 
between intracellular and soluble compartments. The ELISA analy-
ses showed that the production of TNFa but not IL-la was en-
hanced by SEB. In consideration of the synergism between IL-1a 
Table VI. Effects of Toxins, PMA, and Retinoic Acid on IL-la 
and TNFa Production by Human Keratinocytes' 
Materials Added 
None 
SEB (200 ng/ml) 
Pertussis toxin (200 ng/ml) 
Diphtheria toxin (200 ng/ml) 
AlI-trailS retinoic acid (0.8 ,umol/ l) 
PMA (20 nmo/I) 
Concentration ill 
Supernatants Measured 
by ELISA 
IL-la 
(pg/ml) 
24 
22 
20 
69& 
21 
45b 
TNFa 
(pg/ml) 
Undetectable 
8 
Undetectable 
Undetectable 
6 
25 
-The indicated concentration of materials was added to scmiconflucnt human kcrati-
nocytes in 24-wcll plates (2 ml medium/culture) . After cultivating for 2 d, the superna-
tants were collected and IL- la and TNFa concentrations were assayed by ELISA. The 
data represen t means of triplicate assay. 
~p < 0.01, compared with nOlle group. 
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and TNFa, such augmentation of TN Fa production seems to con-
tribute to the observed augmentation ofT-cell-activating activity. 
However, it is possible that cytokine(s) other than TNFa are also 
involved in the T-cell - proliferating activity of supernatants from 
SEB-exposed keratinocytes. The stimulative ability of SEB for 
TNFa is characteristic because pertussis toxin and diphtheria toxin 
did not induce TNFa production by keratinocytes. Activation ofT 
cells by superantigens has been reported to require costimulatory 
signals in which cytokines are presumably involved [45] . It is thus 
possible that the induction of keratinocyte cytokines by the toxins 
may enhance the ability of keratinocytes to serve as accessory cells 
for the T-cell response to superantigens. 
Previous investigations have shown that staphylococcal toxins 
stimulate cytokine pl'Oduction in monocytes [12-15]. TSST-1 in-
duces monocytes to secrete IL-1 [12], TNF [12-15], and IFN-y 
[15] . Recent studies have suggested that SE-mediated stimulation of 
monocytes to release TNF is a consequence of binding to and signa-
ling through class II present on the monocytes, and that IFN-y-
induced upregulation of class II leads to enhanced responsiveness 
[16]. In the present studies, however, enhanced keratinocyte ex-
pression of class II molecules resulting from exposure to exogenous 
IFN-y for 24 h was not paralleled by an increase in SEB-stimulated 
production of cytokine(s). This suggests that surface molecules 
other than class II may be involved in signaling keratinocytes to 
produce cytokine(s). On the other hand, the present studies do not 
definitively rule out the possibility that the class II molecule is the 
only relevant ligand for cytokine production by SEB-stimulated 
keratinocytes. Staining with anti-HLA-DR antibody of human 
keratinocytes subcultured in media alone for 24 h (prior to addition 
of SEB, Table IV, group C) was slightly greater than the back-
ground staining with an irrelevant control antibody (0 .17 ± 0.02 
versus 0.12 ± 0.01), perhaps indicative of low level induction of 
class II expression on cultured keratinocytes in the absence of exog-
enous IFN-y. Such low levels of class II expression might be suffi-
cient for transducing a signal for cytokine production. Interestingly, 
we have recently found that elevation of intracellular calcium is 
induced by exposure to SEB in keratinocytes not expressing class II 
molecules~, providing another evidence for the involvement of 
molecule(s) other than class II in the stimulation of keratinocytes 
with SEB. 
On the basis of the present findings, cutaneous effects of bacterial 
toxins may be categorized into at least three types. One is the "su-
perantigen reaction, " in which skin-infiltrating T cells bearing par-
ticular V[J elements respond to the toxins in the presence of LC 
and/or class 11+ keratinocytes. A second is the capacity of toxins to 
directly or indirectly affect the production by cells in the skin of 
soluble modulators and/or mediators of cutaneous inflammation. 
Among such cells, keratinocytes are quantitatively the major 
population, and keratinocytes produce cytokines with T-cell-
proliferative activity in response to bacterial toxins. Cutaneous mast 
cells have also been shown to react to bacterial toxins such as SEB by 
releasing histamine [46] , although in this case the SEB was felt to 
stimulate mast cells indirectly by triggering release from sensory 
neurons of the mast cell- degranulating agent, substance P. The 
third type of toxin-mediated intracutaneous activity is in fact the 
earliest one to have been studied, i.e., the capacity of exotoxins such 
as ExT to induce intercellular separation of granular layer keratino-
cytes via an incompletely understood noncytotoxic mechanism (re-
viewed in [47]) . Whether such activity depends on the proposed 
binding of ExT to desmoglein 1** and whether ExT-stimulated 
production by keratinocytes of TN Fa and perhaps other cytokines 
involves binding to the same molecules are obvious experimentally 
approachable questions for future studies. 
~ Wakita H , Tokura Y, Takigawa M: Augmentation of interferon-y-
induced keratinocyte intercellular adhesion molecu le-1 expression by bacte-
rial superantigens (manuscript in preparation). 
•• Takagi Y, Futamura S, Asada Y: Action site of exfo liative toxin on 
keratinocytes (abstr). ] I" vest Dermatol 94:52A, 1990 
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In addition to the cutaneous diseases well known to be causally 
related to bacterial toxins, such as scalded skin syndrome, other skin 
disorders may well be influenced by superantigenic bacterial exo-
proteins. We have observed that malignant T cells from some pa-
tients with cutaneous T-cell lymphoma (CTCL) are capable of pro-
liferating in response to bacterial toxins in a manner that is restricted 
by Vb usage, suggesting a potential role for toxins in the pathogene-
sis of this poorly understood group of diseases [48] . The skin of 
patients with other incompletely understood diseases such as psoria-
sis and atopic dermatitis is frequently colonized and/or superin-
fected with pathogenic bacteria capable of toxin elaboration 
[49,50] , and clinical improvement of the underlying disease is fre-
quently seen coincident with institution of antibacterial therapy 
[SO]. The possibility that such clinical improvement is related to 
either decreased superantigenic stimulation within the prominent 
Tcell infiltrates present in lesional skin and/or altered elaboration of 
keratinocyte-derived immunomodulatory cytokines such as TNFa 
should certainly be kept in mind. 
This work was supported i" part by NIHgraflts 1CA43058 (RLE) alld AI27404 
(RET) a"d a Grant-it/-Aid Jor Scientific Research (05670726) frOIll the Ministry 
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